Article metrics

Download PDFPDF

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2022

AbstractFullPdf
Dec 2019110
Jan 202011112
Feb 202026263
Mar 202020201
Apr 202016166
May 2020272719
Jun 202013133
Jul 202015153
Aug 2020151512
Sep 202022221
Oct 202037372
Nov 202018172
Dec 2020664
Jan 202111112
Feb 202117178
Mar 2021262610
Apr 2021222211
May 202119195
Jun 202115153
Jul 202122225
Aug 202127269
Sep 202136368
Oct 2021363611
Nov 202119193
Dec 202138389
Jan 202218207
Feb 202217174
Mar 202234354
Apr 202231346
May 2022353611
Jun 202227273
Total677682177